Effects of Wnt5a protein on proliferation and apoptosis in JAR choriocarcinoma cells

Molecular Medicine Reports

Volumn 4, Issue 1, 2011, Pages 99-104

  Peng, Sha ^a   Zhang, Junlin ^a   Chen, Jiahuan ^a   Wang, Huayan ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

Apoptosis; Choriocarcinoma; Proliferation; Wnt5a

Indexed keywords

WNT5A PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CHORIOCARCINOMA; CYTOTROPHOBLAST; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PLACENTA DISORDER; PLACENTAL CHORIOCARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CHORIOCARCINOMA; FEMALE; HUMANS; PREGNANCY; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS; WNT PROTEINS;

EID: 78651384502     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.383     Document Type: Article

References (32)

1. Janneau JL, Maldonado-Estrada J, Tachdjian G, Miran I, Motte N, Saulnier P, Sabourin JC, Cote JF, Simon B, Frydman R, Chaouat G and Bellet D: Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab 87: 5336-5339, 2002. (Pubitemid 35316382)
2. Karmakar S, Dhar R and Das C: Inhibition of cytotrophoblastic (JEG-3) cell invasion by interleukin 12 involves an interferon gamma-mediated pathway. J Biol Chem 279: 55297-55307, 2004. (Pubitemid 40066527)
3. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR III and Nusse R: Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452, 2003. (Pubitemid 36626997)
4. Miller JR, Hocking AM, Brown AM and Moon RT: Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18: 7860-7872, 1999.
5. Moon RT, Brown JD and Torres M: Wnts modulate cell fate and behaviour during vertebrate development. Trends Genet 13: 157-162, 1997.
6. Wodarz A and Nusse R: Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14: 59-88, 1998. (Pubitemid 29001449)
7. Moon RT, Kohn AD, De Ferrari GV and Kaykas A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701, 2004.
8. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480, 2006.
9. Oishi I, Suzuki H, Onishi N, Takada R, Kani S, Ohkawara B, Koshida I, Suzuki K, Yamada G, Schwabe GC, Mundlos S, Shibuya H, Takada S and Minami Y The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8: 645-654, 2003. (Pubitemid 36880848)
10. Slusarski DC, Yang-Snyder J, Busa WB and Moon RT: Modulation of embryonic intracellular Ca2+ signaling by Wnt-5A. Dev Biol 182: 114-120, 1997. (Pubitemid 27107320)
11. Kuhl M, Sheldahl LC, Malbon CC and Moon RT: Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J Biol Chem 275: 12701-12711, 2000. (Pubitemid 30241421)
12. Sidhu SS, Nawroth R, Retz M, Lemjabbar-Alaoui H, Dasari V and Basbaum C: EMMPRIN regulates the canonical Wnt/beta-catenin signaling pathway, a potential role in accelerating lung tumorigenesis. Oncogene 29: 4145-4156, 2010.
13. Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, Yasui W and Kikuchi A: Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 29: 2036-2046, 2010.
14. Hibi K, Mizukami H, Goto T, Kitamura Y, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H and Sanada Y: WNT5A gene is aberrantly methylated from the early stages of colorectal cancers. Hepatogastroenterology 56: 1007-1009, 2009.
15. Xu P, Wang Y, Piao Y, Bai S, Xiao Z, Jia Y, Luo S and Zhuang L: Effects of matrix proteins on the expression of matrix metalloproteinase-2, -9, and -14 and tissue inhibitors of metalloproteinases in human cytotrophoblast cells during the first trimester. Biol Reprod 65: 240-246, 2001.
16. Pattillo RA, Gey GO, Delfs E, Huang WY, Hause L, Garancis DJ, Knoth M, Amatruda J, Bertino J, Friesen HG and Mattingly RF: The hormone-synthesizing trophoblastic cell in vitro: a model for cancer research and placental hormone synthesis. Ann NY Acad Sci 172: 288-298, 1971.
17. Cadigan KM and Nusse R: Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305, 1997. (Pubitemid 28023954)
18. Huang Y, Liu G, Zhang B, Xu G, Xiong W and Yang H: Wnt-5a regulates proliferation in lung cancer cells. Oncol Rep 23: 177-181, 2010.
19. Kremenevskaja N, von Wasielewski R, Rao AS, Schöfl C, Andersson T and Brabant G: Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24: 2144-2154, 2005. (Pubitemid 40516581)
20. Yu JM, Jun ES, Jung JS, Suh SY, Han JY, Kim JY and Jung JS: Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett 257: 172-181, 2007. (Pubitemid 47538822)
21. Ripka S, König A, Buchholz M, Wagner M, Sipos B, Klöppel G, Downward J, Gress T and Michl P: WNT5A-target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28: 1178-1187, 2007. (Pubitemid 47062676)
22. Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R and Jones SN: Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4: 4349-4360, 2003. (Pubitemid 37491096)
23. Ying J Li H, Yu J, Ng KM, Poon FF, Wong SC, Chan AT, Sung JJ and Tao Q: WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res 14: 55-61, 2008. (Pubitemid 351377978)
24. Torii K, Nishizawa K, Kawasaki A, Yamashita Y, Katada M, Ito M, Nishimoto I, Terashita K, Aiso S and Matsuoka M: Antiapoptotic action of Wnt5a in dermal fibroblasts is mediated by the PKA signaling pathways. Cell Signal 20: 1256-1266, 2008.
25. Vuga LJ, Ben-Yehudah A, Kovkarova-Naumovski E, Oriss T, Gibson KF, Feghali-Bostwick C and Kaminski N: WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol 41: 583-589, 2009.
26. Brown JM and Attardi LD: The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5: 231-237, 2005. (Pubitemid 40314954)
27. Torres MA, Yang-Snyder JA, Purcell SM, DeMarais AA, McGrew LL and Moon RT: Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative Cadherin in early Xenopus develop- ment. J Cell Biol 133: 1123-1137, 1996.
28. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ and Yang Y Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162: 899-908, 2003. (Pubitemid 37087729)
29. Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J and Matsumoto K: The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23: 131-139, 2003. (Pubitemid 36008507)
30. Mikels AJ and Nusse R: Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4: 570-582, 2006.
31. Van de Wetering M, Sancho E, Verweij C, et al: The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250, 2002.
32. Wallingford JB, Vogeli KM and Harland RM: Regulation of convergent extension in Xenopus by Wnt5a and Frizzled-8 is independent of the canonical Wnt pathway. Int J Dev Biol 45: 225-227, 2001.